|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 329.89 USD | -3.02% |
|
-4.51% | +26.57% |
| 04/12 | Amgen Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 01:45 PM | |
| 04/12 | Amgen Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-03-2025 10:00 AM |
| Capitalization | 18TCr 15TCr 14TCr 13TCr 25TCr 15,98700Cr 27TCr 1,67300Cr 65TCr 7,55100Cr 67TCr 65TCr 27,60800Cr | P/E ratio 2025 * |
25.2x | P/E ratio 2026 * | 23.9x |
|---|---|---|---|---|---|
| Enterprise value | 22TCr 19TCr 18TCr 17TCr 31TCr 19,99900Cr 34TCr 2,09300Cr 81TCr 9,44500Cr 83TCr 82TCr 34,53600Cr | EV / Sales 2025 * |
6.12x | EV / Sales 2026 * | 5.89x |
| Free-Float |
99.85% | Yield 2025 * |
2.9% | Yield 2026 * | 3.06% |
Last Transcript: Amgen Inc.
| 1 day | -3.02% | ||
| 1 week | -4.51% | ||
| Current month | -4.51% | ||
| 1 month | +3.14% | ||
| 3 months | +16.31% | ||
| 6 months | +14.90% | ||
| Current year | +26.57% |
| 1 week | 328.63 |  | 346.38 |
| 1 month | 314 | | 346.38 |
| Current year | 257.05 | | 346.38 |
| 1 year | 253.3 | | 346.38 |
| 3 years | 211.71 | | 346.85 |
| 5 years | 198.64 | | 346.85 |
| 10 years | 133.64 | | 346.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 62 | 01/05/2012 |
Peter Griffith
DFI | Director of Finance/CFO | 66 | 01/01/2020 |
Esteban Santos
COO | Chief Operating Officer | 58 | 25/07/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 62 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 64 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 70 | 01/01/2012 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 5.08% | 135 M€ | +8.98% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.02% | -4.51% | +20.25% | +15.79% | 18TCr | |
| -0.41% | -6.06% | +22.37% | +173.58% | 90TCr | |
| -0.27% | -2.41% | +35.05% | +12.95% | 49TCr | |
| -1.15% | -0.71% | +28.33% | +37.90% | 40TCr | |
| +0.26% | +1.14% | +21.30% | +0.44% | 33TCr | |
| +0.58% | -2.73% | +28.01% | +20.71% | 28TCr | |
| +0.19% | +2.49% | +18.48% | +24.80% | 26TCr | |
| -1.16% | -4.87% | -3.70% | -9.35% | 25TCr | |
| +1.24% | -2.33% | -59.84% | -31.25% | 21TCr | |
| -1.14% | -3.67% | +29.80% | +37.78% | 15TCr | |
| Average | -0.30% | -2.37% | +14.01% | +28.34% | 34.47TCr | |
| Weighted average by Cap. | -0.13% | -2.83% | +18.15% | +55.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.63TCr 3.12TCr 2.93TCr 2.73TCr 5.04TCr 3,26900Cr 5.48TCr 34TCr 13TCr 1,54400Cr 14TCr 13TCr 5,64600Cr | 3.69TCr 3.17TCr 2.97TCr 2.77TCr 5.11TCr 3,31700Cr 5.56TCr 35TCr 13TCr 1,56600Cr 14TCr 14TCr 5,72700Cr |
| Net income | 734.47Cr 631.35Cr 591.44Cr 551.26Cr 1.02TCr 66TCr 1.11TCr 6.92TCr 2.67TCr 31TCr 2.76TCr 2.7TCr 1,14100Cr | 737.45Cr 633.91Cr 593.84Cr 553.5Cr 1.02TCr 66TCr 1.11TCr 6.95TCr 2.68TCr 31TCr 2.77TCr 2.71TCr 1,14600Cr |
| Net Debt | 4.46TCr 3.83TCr 3.59TCr 3.35TCr 6.18TCr 4,01200Cr 6.72TCr 42TCr 16TCr 1,89500Cr 17TCr 16TCr 6,92800Cr | 3.93TCr 3.38TCr 3.16TCr 2.95TCr 5.44TCr 3,53500Cr 5.92TCr 37TCr 14TCr 1,66900Cr 15TCr 14TCr 6,10400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 329.89 $ | -3.02% | 28,97,992 |
| 04/25/04 | 340.16 $ | -1.52% | 36,95,846 |
| 03/25/03 | 345.42 $ | +2.09% | 28,39,394 |
| 02/25/02 | 338.36 $ | +0.26% | 24,46,819 |
| 01/25/01 | 337.49 $ | -2.31% | 23,84,122 |
Delayed Quote Nasdaq, December 06, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition